Meloxicam Zentiva

Meloxicam, the active ingredient in Meloxicam Zentiva, is a nonsteroidal anti-inflammatory drug presented as an oral tablet for oral use. It treats osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and acute pain in adults.

GNH USA supplies Meloxicam Zentiva as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Meloxicam is an NSAID that reduces inflammation and pain in several musculoskeletal conditions.

Osteoarthritis: alleviates joint pain and improves mobility. Rheumatoid arthritis: decreases inflammation and slows disease progression. Ankylosing spondylitis: reduces spinal stiffness and pain. Acute pain: provides rapid relief of moderate to severe pain episodes.

Adverse reactions may vary in frequency and severity.

Common Side Effects: - Dyspepsia or stomach upset - Headache - Dizziness - Peripheral edema - Skin rash or itching - Elevated liver enzymes

Serious or Rare Side Effects: - Gastrointestinal bleeding or ulcer perforation - Cardiovascular thrombotic events (e.g., myocardial infarction, stroke) - Acute renal failure or worsening of chronic kidney disease - Severe skin reactions such as Stevens‑Johnson syndrome - Hepatotoxicity with jaundice - Anaphylactic or severe hypersensitivity reactions

Before prescribing meloxicam, clinicians should evaluate patient‑specific risk factors. - Gastrointestinal risk: avoid in patients with active ulcers or a history of GI bleeding. - Cardiovascular caution: use cautiously in patients with heart disease or stroke history. - Renal monitoring: adjust or discontinue if renal function declines. - Hypersensitivity: discontinue immediately if rash, swelling, or anaphylaxis occurs. - Pregnancy and lactation: avoid unless benefits outweigh potential risks. - Store below 25°C: keep in the original container, protect from moisture.

Meloxicam may interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased bleeding risk. - Other NSAIDs or aspirin: heightened gastrointestinal toxicity. - Lithium: elevated lithium serum levels. - Methotrexate: reduced clearance leading to toxicity. - Cyclosporine: increased nephrotoxicity.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: possible reduction in renal function. - Diuretics: risk of electrolyte imbalance and renal impairment. - SSRIs or SNRIs: additive bleeding risk. - Beta‑blockers: may blunt antihypertensive effect. - Corticosteroids: synergistic GI ulcer risk.